Market Research Report

Global Intravenous Infusion Pump Market Report By Product (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps, Others), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11220631
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Intravenous Infusion Pump Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

An intravenous infusion pump is a medical device used to deliver fluids, medications, and nutrients directly into a patient's bloodstream through a vein. These devices are typically used in hospitals, clinics, and other healthcare settings to deliver a precise and controlled amount of fluids or medications over a set period of time. Intravenous infusion pumps are designed to accurately control the flow rate of fluids or medications into the patient's bloodstream. They typically consist of a pump mechanism, a reservoir for the fluid or medication, and a delivery system that is connected to the patient's vein through an intravenous catheter. These pumps can be programmed to deliver a specific volume of fluid or medication over a set period of time, allowing for precise dosing and delivery. They are commonly used to administer intravenous antibiotics, chemotherapy drugs, and other medications that require a controlled and precise delivery. Intravenous infusion pumps may also have additional features, such as the ability to detect air bubbles in the tubing or to deliver multiple medications simultaneously. Some models may also be portable or wearable, allowing patients to receive treatment at home or while on the go.

Market Dynamics

As the global population ages and the incidence of diseases which are chronic in nature, such as cancer, diabetes, and cardiovascular disease, continues to rise, the demand for intravenous infusion pumps is expected to increase. These pumps are commonly used to deliver medications and fluids to patients with chronic conditions, and as the number of people with these conditions increases, so too will the demand for infusion pumps. New and innovative intravenous infusion pumps that are more accurate, reliable, and user-friendly. These pumps often include features such as wireless connectivity, touchscreen interfaces, and automated monitoring and alerts, which make them easier to use and improve patient safety. As healthcare costs continue to rise and hospitals look for ways to reduce readmissions, there is a growing demand for home healthcare services. Intravenous infusion pumps are an important component of many home healthcare treatments, as they allow patients to receive medication and fluids at home without needing to visit a hospital or clinic. The number of surgical procedures being performed globally is on the rise, driving the demand for intravenous infusion pumps. These pumps are commonly used during surgery to deliver anaesthesia and other medications, and as the number of surgical procedures increases, so too will the demand for infusion pumps. In many countries, healthcare systems provide reimbursement for the use of intravenous infusion pumps, which helps to drive demand for these devices. Reimbursement policies vary by country and by type of infusion pump, but in general, favourable policies are expected to assist the growth of the market.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous infusion pump. The growth and trends of intravenous infusion pump industry provide a holistic approach to this study. 

Market Segmentation

This section of the intravenous infusion pump market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product
  • Volumetric Infusion Pumps
  • Insulin Infusion Pumps
  • Syringe Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient Controlled Analgesia (PCA)
  • Implantable Infusion Pumps
  • Others

By Disease Indication
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Infusion Pump market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Intravenous Infusion Pump Market Share by Region (Representative Graph)

Global Intravenous Infusion Pump Market Share
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous infusion pump market include Baxter International, B. Braun Melsungen AG, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care Inc., Terumo Corporation, Mindray, Moog Inc., IRadimed Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . INTRAVENOUS INFUSION PUMP – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product
           3.7.2 Market Attractiveness Analysis By Disease Indication
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Volumetric Infusion Pumps Historic and Forecast Sales by Regions
       6.5 Insulin Infusion Pumps Historic and Forecast Sales by Regions
       6.6 Syringe Infusion Pumps Historic and Forecast Sales by Regions
       6.7 Enteral Infusion Pumps Historic and Forecast Sales by Regions
       6.8 Ambulatory Infusion Pumps Historic and Forecast Sales by Regions
       6.9 Patient Controlled Analgesia (PCA) Historic and Forecast Sales by Regions
       6.10. Implantable Infusion Pumps Historic and Forecast Sales by Regions
       6.11 Others Historic and Forecast Sales by Regions
 
7 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY DISEASE INDICATION
       7.1 Overview by Disease Indication
       7.2 Historical and Forecast Data
       7.3 Analysis by Disease Indication
       7.4 Chemotherapy Historic and Forecast Sales by Regions
       7.5 Diabetes Historic and Forecast Sales by Regions
       7.6 Gastroenterology Historic and Forecast Sales by Regions
       7.7 Analgesia/Pain Management Historic and Forecast Sales by Regions
       7.8 Pediatrics/Neonatology Historic and Forecast Sales by Regions
       7.9 Hematology Historic and Forecast Sales by Regions
       7.10. Others Historic and Forecast Sales by Regions
 
8 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS INFUSION PUMP COMPANIES
       9.1. Intravenous Infusion Pump Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF INTRAVENOUS INFUSION PUMP INDUSTRY
       10.1. Top Companies Market Share Analysis
       10.2. Market Concentration Rate
       10.3. Baxter International
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. B. Braun Melsungen AG
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Medtronic
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Micrel Medical Devices SA
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Boston Scientific Corporation
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. CareFusion Corporation
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Fresenius Kabi
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Smiths Medical
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. F. Hoffmann-La Roche Ltd.
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Tandem Diabetes Care Inc.
           10.12.1. Company Overview
           10.12.2. Company Revenue
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Terumo Corporation
           10.13.1. Company Overview
           10.13.2. Company Revenue
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. Mindray
           10.14.1. Company Overview
           10.14.2. Company Revenue
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. Moog Inc.
           10.15.1. Company Overview
           10.15.2. Company Revenue
           10.15.3. Products
           10.15.4. Recent Developments
       10.16. IRadimed Corporation
           10.16.1. Company Overview
           10.16.2. Company Revenue
           10.16.3. Products
           10.16.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
  •  Insulin Infusion Pumps Market Sales by Geography (USD MN)
  •  Syringe Infusion Pumps Market Sales by Geography (USD MN)
  •  Enteral Infusion Pumps Market Sales by Geography (USD MN)
  •  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
  •  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
  •  Implantable Infusion Pumps Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis Market by Disease Indication (USD MN)
  •  Chemotherapy Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Gastroenterology Market Sales by Geography (USD MN)
  •  Analgesia/Pain Management Market Sales by Geography (USD MN)
  •  Pediatrics/Neonatology Market Sales by Geography (USD MN)
  •  Hematology Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Intravenous Infusion Pump Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Intravenous Infusion Pump Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Intravenous Infusion Pump Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Disease Indication
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Volumetric Infusion Pumps Market Sales by Geography (USD MN)
  •  Insulin Infusion Pumps Market Sales by Geography (USD MN)
  •  Syringe Infusion Pumps Market Sales by Geography (USD MN)
  •  Enteral Infusion Pumps Market Sales by Geography (USD MN)
  •  Ambulatory Infusion Pumps Market Sales by Geography (USD MN)
  •  Patient Controlled Analgesia (PCA) Market Sales by Geography (USD MN)
  •  Implantable Infusion Pumps Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Disease Indication (USD MN)
  •  Chemotherapy Market Sales by Geography (USD MN)
  •  Diabetes Market Sales by Geography (USD MN)
  •  Gastroenterology Market Sales by Geography (USD MN)
  •  Analgesia/Pain Management Market Sales by Geography (USD MN)
  •  Pediatrics/Neonatology Market Sales by Geography (USD MN)
  •  Hematology Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Companies Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials